Ontology highlight
ABSTRACT:
SUBMITTER: Bhavesh R
PROVIDER: S-EPMC5304808 | biostudies-other | 2015 Nov
REPOSITORIES: biostudies-other
Bhavesh Riju R Lechuga-Vieco Ana V AV Ruiz-Cabello Jesús J Herranz Fernando F
Nanomaterials (Basel, Switzerland) 20151104 4
Iron oxide nanoparticles have long been studied as a T₂ contrast agent in MRI due to their superparamagnetic behavior. T₁-based positive contrast, being much more favorable for clinical application due to brighter and more accurate signaling is, however, still limited to gadolinium- or manganese-based imaging tools. Though being the only available commercial positive-contrast agents, they lack an efficient argument when it comes to biological toxicity and their circulatory half-life in blood. Th ...[more]